| Dr Adamatta Mudada, PHARMD | |
|
5 Walker Rd, Edgewood, NM 87015-8786 | |
| (505) 281-0950 | |
| Not Available |
| Full Name | Dr Adamatta Mudada |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 5 Walker Rd, Edgewood, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114649951 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP00009741 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adamatta Mudada, PHARMD 12900 Carrie Pl Se, Albuquerque, NM 87123-3804 Ph: (505) 410-0363 | Dr Adamatta Mudada, PHARMD 5 Walker Rd, Edgewood, NM 87015-8786 Ph: (505) 281-0950 |
News Archive
Baxter International Inc., in conjunction with DynPort Vaccine Company LLC, a CSC Company, today presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter's Vero cell culture platform and does not contain an adjuvant or preservatives. The data were presented at the International Congress on Infectious Disease (ICID) in Miami, Florida.
A team of researchers at the Medical University of South Carolina has been awarded $3.75 million by the National Center for Advancing Translational Sciences to enhance an existing informatics tool known as "informatics for integrating biology and the bedside" or I2B2.
There are 256 Democrats in the House, but some moderates have balked at inclusion of a public plan, "especially one linked to Medicare rates," CQ Politics reports (10/21).
The April issue of USAID's "PRH Connect" e-newsletter features a round-up of top news articles; a partnership profile of the Alliance for Reproductive, Maternal and Newborn Health; notes from the field highlighting the DELIVER Project's new photo blog, and links to various resources, publications and research.
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).
› Verified 3 days ago
Cynthia Batie, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2b State Road 344, Edgewood, NM 87015 Phone: 505-286-9040 | |
Ms. Helen J. Weldon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2b State Road 344, Edgewood, NM 87015 Phone: 505-286-9040 | |
Mr. John Robert Alvis, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 66 State Road 344, Edgewood, NM 87015 Phone: 505-286-3053 Fax: 505-286-3055 | |
Reid Rowe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2b State Road 344, Edgewood, NM 87015 Phone: 505-286-9040 Fax: 505-286-9221 | |
Mr. Robert Andrews Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2b Highway 344, Edgewood, NM 87015 Phone: 505-281-5050 | |
Apryl Swainston, RPH, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5 Walker Rd, Edgewood, NM 87015 Phone: 505-281-0950 |